Samsung Electronics(005930) and its labor union failed to reach an agreement in the post-mediation process conducted under the arbitration of the National Labor Relations Commission.
Celltrion has completed its application to the European Medicines Agency(EMA) for approval of ‘Herzuma SC,’ a subcutaneous formulation of the breast cancer treatment Herzuma, thereby securing a new hyaluronidase-based subcutaneous formulation platform.